Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,038 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Korean guidelines for the prevention of venous thromboembolism.
Bang SM, Jang MJ, Oh D, Kim YK, Kim IH, Yoon SS, Yoon HJ, Kim CS, Park S; Korean Society of Thrombosis and Hemostasis. Bang SM, et al. Among authors: oh d. J Korean Med Sci. 2010 Nov;25(11):1553-9. doi: 10.3346/jkms.2010.25.11.1553. Epub 2010 Oct 26. J Korean Med Sci. 2010. PMID: 21060742 Free PMC article.
Prevention of venous thromboembolism, 2nd edition: Korean Society of Thrombosis and Hemostasis Evidence-based Clinical Practice Guidelines.
Bang SM, Jang MJ, Kim KH, Yhim HY, Kim YK, Nam SH, Hwang HG, Bae SH, Kim SH, Mun YC, Kim YK, Kim I, Choi WI, Jung CW, Park NH, Choi NK, Park BJ, Oh D; Korean Society of Thrombosis and Hemostasis. Bang SM, et al. Among authors: oh d. J Korean Med Sci. 2014 Feb;29(2):164-71. doi: 10.3346/jkms.2014.29.2.164. Epub 2014 Jan 28. J Korean Med Sci. 2014. PMID: 24550640 Free PMC article.
Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome.
Lee H, Kang E, Kang HG, Kim YH, Kim JS, Kim HJ, Moon KC, Ban TH, Oh SW, Jo SK, Cho H, Choi BS, Hong J, Cheong HI, Oh D. Lee H, et al. Among authors: oh sw, oh d. Korean J Intern Med. 2020 Jan;35(1):25-40. doi: 10.3904/kjim.2019.388. Epub 2020 Jan 2. Korean J Intern Med. 2020. PMID: 31935318 Free PMC article. Review.
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon SS, Kavanagh D, Haller H; 311 Study Group. Rondeau E, et al. Kidney Int. 2020 Jun;97(6):1287-1296. doi: 10.1016/j.kint.2020.01.035. Epub 2020 Mar 6. Kidney Int. 2020. PMID: 32299680 Free article. Clinical Trial.
Distinct genetic profile with recurrent population-specific missense variants in Korean adult atypical hemolytic uremic syndrome.
Yun JW, Oh J, Lee KO, Lee SJ, Kim JO, Kim NK, Kim JS, Koh Y, Yoon SS, Yhim HY, Jo SK, Park Y, Lee JE, Park J, Lee JW, Kim SH, Kim HJ, Oh D; Korean TTP Registry investigators; aHUS working group. Yun JW, et al. Among authors: oh j, oh d. Thromb Res. 2020 Oct;194:45-53. doi: 10.1016/j.thromres.2020.06.016. Epub 2020 Jun 9. Thromb Res. 2020. PMID: 33213850
4,038 results